PT Tempo Scan Pacific Tbk and its subsidiaries are part of the Tempo Group, a group of companies which commenced its business activities through the establishment of PT PD Tempo on November 3, 1953 in the trading business of pharmaceutical products. As one of the leaders in the Indonesian Pharmaceutical Industry, Tempo Scan Group works wholeheartedly to provide high quality products. In addition, its affordable price proposition and continuous innovation makes these products a primary choice for consumers.
Dexa Medica is one of Indonesia’s largest ethical pharmaceutical companies and has become a prominent, well-respected player in the domestic pharmaceutical market. Providing better health care by applying expertise was the foundation on which its founders built the Company. Dexa was established in 1969 in the province of Palembang, in the South of Sumatra Island, Indonesia with the aim of supplying medicine to Palembang and its surrounding areas. In 1984 Dexa further strengthened its position as a nationwide player by strategically relocating its marketing office to Jakarta. Since 1994, from year to year, Dexa’s domestic sales have grown steadily higher than the Indonesian pharmaceuticals industry. In 2001, PT Ferron Par Pharmaceuticals was established to provide additional production and marketing capacities in support of this high growth, and to anticipate the global competition. Dexa is now solidifying its excellent management team while staying focused on its core business of producing and marketing quality pharmaceutical goods. In addition, Dexa is taking up the challenge of becoming a regional player and achieving a respectable global presence.
Kalbe International is an international marketing company that mainly handles the trading/export transaction of total Kalbe Farma’s group of business. Established in 1966, PT Kalbe Farma has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. Throughout its more than 40-year history, the Company has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching international markets to transform itself into an integrated consumer health and nutrition enterprise with unrivaled innovation, marketing, branding, distribution, financial strength and R&D. Kalbe International Marketing Division is currently in 12 countries including Singapore, Cambodia, Malaysia, Myanmar, Philippines, Vietnam, Sri Lanka, South Africa, Nigeria, Thailand, and UAE. Kalbe’s formulations are manufactured under stringent quality control of GMP and provides a comprehensive range of pharmaceutical formulations in every major therapeutic categories of customer needs. The company has succeeded in promoting its brands as the undisputed market leader not only in Indonesia, but also in the international markets, establishing such household names across all healthcare and pharmaceutical segments as Procold, Mixagrip, Cypron, Komix, and Prenagen. Today, Kalbe is the largest publicly-listed pharmaceutical company in Southeast Asia with over US$ 1 billion in market capitalization and revenues of over Rp 7 trillion.
Mensa Group is one of the most recognized and respected Healthcare, Logistic and Value added companies in Indonesia. Since 1981, its continuous growth has provided the company with the ability and resources to expand into related businesses. Mensa Group offers accelerated marketing, manufacturing and distribution by enhancing the quality of life through accessible wellness solutions in diversified activities such as:
- – Importing Goods and Trading Raw Materials for Pharmaceutical, Cosmetic, Food and Feed
- – Pharmaceutical and Consumer Goods Manufacturing.
- – International Marketing Distribution.
- – Medical and Dental Equipment Manufacturing and Supplies.
- – Pharmaceutical Hospital/Medical Supplies and Consumer Goods Distribution.
- – Healthcare Business.
- – Online Pharmaceutical Business.